August 2003
Clinical Infectious Diseases;8/15/2003, Vol. 37 Issue 4, pI
Academic Journal
Presents news about infectious diseases. Roche Holding AG's test to detect the virus that causes severe acute respiratory syndrome; Use of microbes by biosensors to detect toxins, pathogens and biochemical agents; U.S. Food and Drug Administration's approval of MedImmune Inc.'s FluMist nasal spray flu vaccine.


Related Articles

  • Roche and BioMed X Collaborate to Develop Nanomaterial-Based Biosensors for Near-Patient Testing.  // Sensors;2/27/2015, p48 

    The article focuses on the collaboration between the healthcare company Roche and biotechnology company BioMed X for the development of nanomaterial-based biosensors intended for near-patient testing.

  • Who will pass the test? Stipp, David // Fortune International (Europe);5/26/2003, Vol. 147 Issue 10, p13 

    Focuses on Roche, the global leader in the clinical diagnostics market, which is trying to develop an early diagnostic test for severe acute respiratory syndrome (SARS). How a diagnostic test which detects the disease in the first few days of infection would reduce the spread of the disease.

  • Zanamivir plus oseltamivir should be stockpiled for pandemic flu.  // PharmacoEconomics & Outcomes News;2/9/2008, Issue 546, p10 

    The article discusses research being done on the stockpiling of Zanamivir from GlaxoSmithKline and oseltamivir from Roche for pandemic influenza. It references a study published online on January 28, 2008. According to a new guidance issued by the European Medicine Agency, Zanamivir along with...

  • Tamiflu side effects cause concern.  // Fire Engineering;Jun2007, Vol. 160 Issue 6, p54 

    This article discusses the influenza drug Tamiflu and whether there is a connection between its use and abnormal psychiatric behavior. Roche Holding AG has denied a link between the medication and several deaths that have occurred after its use, citing that influenza itself could cause...

  • Roche Canada stops distributing oseltamivir. Spurgeon, David // BMJ: British Medical Journal (International Edition);11/5/2005, Vol. 331 Issue 7524, p1041 

    The article states that Roche Canada will stop distributing oseltamivir until the influenza season begins. Canadians were stockpiling Tamiflu because of fears about a flu pandemic. Canada's chief medical officer of health, David Butler-Jones, comments on the government's plan to buy antivirals...

  • Agreements/contracts.  // Medical Device Daily;7/29/2009, Vol. 13 Issue 144, p2 

    The article reports on a joint project started by Roche and Google to demonstate the feasibility of developing a multidisciplinary surveillance, research and response system. The ability to predict and prevent emerging infectious diseases in East Africa will be enhanced by the system. A Genome...

  • Fuzeon makes HIV progress but there's room for more...  // PharmaWatch: Monthly Review;December2004, Vol. 3 Issue 12, p27 

    Reports on the development of Fuzeon, a novel HIV drug, by Roche Pharmaceuticals. Recognition of Fuzeon's novelty by the International Prix Galien; Factors contributing to the success of the drug; Programs initiated by Roche to educate patients and physicians about the use of Fuzeon.

  • 15 August News.  // Clinical Infectious Diseases;Aug2014, Vol. 59 Issue 4, pi 

    The article offers news briefs related to researches done in the field of infectious diseases as of July 2014. Topics discussed include diagnosis of variant Creutzfeldt-Jakob disease (vCJD), local transmission of chikungunya virus in the western hemisphere in Saint Martin, and antibiotic...

  • TOP STORIES.  // MondayMorning;8/11/2008, Vol. 16 Issue 31, p1 

    The article presents news briefs related to pharmaceutical industries and medicine. King Pharmaceuticals Inc. has reported that it has lost almost a fifth of its market value after second-quarter revenue and profit missed analysts' estimates. According to a Great Britain study, Roche Holding AG...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics